Managing Overactive Bladder: The key is persistence

Overactive Bladder (Overactive Bladder – OAB) is a chronic condition characterized by bothersome symptoms such as urinary urgency, urinary frequency, and nocturia, significantly affecting quality of life. To achieve the best treatment outcomes and maintain a normal life, it is extremely important to adhere to the treatment plan prescribed by doctors at University Medical Center Ho Chi Minh City. This article will help patients better understand why persistence is the key to managing OAB.

1. At-Risk Groups and the Importance of Treatment Adherence

1.1. What is Overactive Bladder?

Overactive bladder (OAB) is a clinically diagnosed bladder dysfunction characterized by urinary urgency (a sudden, difficult-to-suppress urge to urinate), urinary frequency, and nocturia, with or without urgency urinary incontinence, in the absence of another clear underlying urological cause [1, 2]. OAB negatively affects quality of life, causing embarrassment, reduced self-esteem, and decreased work productivity [1].

1.2. Who is more likely to develop Overactive Bladder?

Population-based studies in Europe, Canada, South Korea, and the United States show that OAB symptoms occur in 11.8%–16.5% of adults, with similar prevalence among older men and women [1]. Although OAB can cause problems at any age, its prevalence increases with age [1, 3]. This means that as the population ages, OAB will become more common. In addition, certain chronic conditions, such as depression, constipation, neurological disorders, and conditions associated with metabolic syndrome, are significantly associated with OAB [1].

1.3. Why is adherence to Overactive Bladder treatment important?

OAB often requires long-term treatment to control symptoms [1]. Adherence to prescribed medication is very important for achieving the best possible treatment outcomes [1]. In practice, treatment non-adherence may lead to unnecessary dose escalation, switching between medications, invasive tests, and more invasive treatment approaches, while also increasing the cost of disease management [1]. OAB and its treatments can improve urinary symptoms and overall quality of life [4]. Furthermore, treatment adherence is the strongest predictor of reduced annual OAB-related costs [4].

2. Early signs of treatment non-adherence

2.1. Recurrence or worsening of symptoms

One of the clearest signs of non-adherence to OAB treatment is the recurrence or worsening of symptoms. When patients miss medication doses, fail to make lifestyle changes, or discontinue behavioral therapy, symptoms such as urinary urgency, urinary frequency, and nocturia may return with greater severity [1].

2.2. Impact on quality of life

Treatment non-adherence can cause patients’ quality of life to continue to deteriorate. Daily activities may be disrupted, sleep may be disturbed, self-confidence may decline, and participation in social activities may become limited [1, 4]. This can lead to anxiety, depression, and social isolation [4].

2.3. Increased risk of complications

Non-adherence to OAB treatment may increase the risk of complications. In older adults, untreated OAB has been associated with an increased risk of falls, fractures, dermatitis, urinary tract infections, and hospitalization [1, 4].

3. Consequences of treatment non-adherence

3.1. Recurrence of symptoms and reduced treatment effectiveness

Discontinuation rates for OAB treatments, particularly antimuscarinic medications, are very high. A systematic review found that discontinuation rates for antimuscarinic medications ranged from 43% to 83% within the first 30 days [1]. Early discontinuation, sometimes before the full therapeutic effect is achieved, can lead to symptom recurrence and reduced long-term disease control [1].

3.2. Increased treatment costs and healthcare burden

When patients do not adhere to treatment, they may need to try multiple medications, undergo additional tests, or even receive more invasive interventions. This not only increases direct treatment costs but also adds to the burden on the healthcare system [1, 4].

3.3. Psychological and social impact

OAB can have significant psychological and social effects on patients. Embarrassment, anxiety about urinary incontinence, and limitations on social activities may lead to reduced self-esteem, depression, and a significant decline in quality of life [1, 4].

4. Recommendations for maintaining persistence

4.1. Understand the condition and treatment plan

Patients need to receive complete and clear information about OAB, including its causes, symptoms, treatment goals, and available treatment options [1, 4]. A thorough understanding of the condition and treatment plan can help patients develop more realistic expectations about treatment outcomes and potential side effects, thereby improving adherence [1].

4.2. Communicate regularly with your doctor

A good doctor–patient relationship, together with personalized counseling, can significantly improve treatment adherence among people with chronic conditions [1]. Patients should proactively discuss any concerns, medication side effects, or difficulties with adherence with their doctor so that the treatment plan can be appropriately adjusted [1, 4].

4.3. Establish routines and seek family support

To make medication-taking part of a daily routine, patients can use supportive tools such as pill organizers, reminder apps on their phones, or keeping medications in a visible location [1]. Support from family members and loved ones also plays an important role in encouraging and reminding patients to adhere to treatment [1].

4.4. Manage medication side effects

Medication side effects are one of the main reasons patients discontinue OAB treatment [1]. Doctors should discuss potential side effects and how to manage them. In cases of significant side effects, extended-release (ER) formulations or other medications with more favorable side-effect profiles may be considered [1].

5. Frequently Asked Questions (FAQ)

• Can I stop taking my medication when my symptoms improve? No. OAB is a chronic condition, and stopping medication on your own when symptoms improve may lead to recurrence and reduce long-term treatment effectiveness [1]. Always consult your doctor before making any changes to your treatment plan.
• Is it a problem if I forget to take my medication a few times? Frequent missed doses may reduce treatment effectiveness and cause symptoms to recur. Try to take your medication at the same time every day. If you frequently forget, discuss this with your doctor to find a better way to manage your medication [1].
• How can I remember to take my medication on time? Patients can use supportive tools such as pill organizers, phone alarms, or linking medication-taking to another daily activity, such as brushing their teeth or having breakfast [1].
• Is there a way to reduce the side effects of OAB medication? Discuss any side effects you are experiencing with your doctor. Your doctor may adjust the dosage, change the medication, or recommend measures to alleviate the side effects, such as drinking more water to relieve dry mouth [1].
• When should I return for a follow-up visit? Regular follow-up visits are important for your doctor to evaluate treatment effectiveness, monitor side effects, and adjust the treatment plan if necessary. Follow your doctor’s recommended follow-up schedule [1].

6. References

• [1] Dhaliwal, P., & Wagg, A. (2016). Overactive bladder: strategies to ensure treatment compliance and adherence. Clinical Interventions in Aging. https://pmc.ncbi.nlm.nih.gov/articles/PMC4902140/. Truy cập: 2026-03-17.
• [2] Robinson, D., O’Kane, M., & Cardozo, L. (2023). Adherence to Overactive Bladder Syndrome Treatments Recent Developments and Future Perspectives. International Journal of Women's Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC10224686/. Truy cập: 2026-03-17.
• [3] Enemchukwu, E. A., Subak, L. L., & Markland, A. (2022). Barriers and facilitators to overactive bladder therapy adherence. Neurourology and urodynamics. https://pmc.ncbi.nlm.nih.gov/articles/PMC11424050/. Truy cập: 2026-03-17.
• [4] Enemchukwu, E. A., Subak, L. L., & Markland, A. (2022). Barriers and facilitators to overactive bladder therapy adherence. Neurourology and urodynamics. https://pmc.ncbi.nlm.nih.gov/articles/PMC11424050/. Truy cập: 2026-03-17.

The information above is for reference purposes only and is not intended as medical advice. Please contact your doctor for detailed medical consultation.